Target intelligence / Profile preview

Salmonella Paratyphi A flagellin (H:a antigen) (FliC)

Target
FliC
Molecular classification
Bacterial surface protein, Flagellar protein, Toll-like receptor 5 (TLR5) agonist, Other
01

Overview

Salmonella Paratyphi A flagellin, specifically the H:a antigen, is the primary structural protein of the flagellar filament in Salmonella enterica serovar Paratyphi A. Encoded by the fliC gene, this protein is essential for bacterial motility and chemotaxis, enabling the pathogen to navigate the host environment and invade intestinal epithelial cells (UniProt Q5PC24). The H:a antigen is highly immunogenic and serves as a major target for the host's adaptive immune system during infection with paratyphoid fever. It also acts as a potent agonist for Toll-like receptor 5 (TLR5), initiating innate immune signaling pathways that lead to the production of pro-inflammatory cytokines (PubMed: 11242089). In therapeutic development, flagellin is a key component of vaccine candidates, often serving as both a protective antigen and a carrier protein for O-specific polysaccharides to enhance overall immunogenicity (PubMed: 23414380). Targeting this protein aims to induce neutralizing antibodies that inhibit bacterial motility and facilitate opsonophagocytosis, thereby preventing the systemic spread of the pathogen (PubMed: 28433448). Given the rising antibiotic resistance in Salmonella Paratyphi A, the H:a antigen remains a critical focus for the development of effective glycoconjugate and subunit vaccines (WHO).

Other names
Phase 1 flagellinH:a antigenFliC proteinFlagellar filament structural protein
02

Mechanism of action

The target acts as an immunogen in vaccine formulations, where it induces the production of H:a-specific antibodies that block bacterial motility and promote opsonophagocytosis, while also serving as a TLR5 agonist to enhance the innate immune response.

03

Biological functions

Bacterial motilityChemotaxisImmune responseOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Injection site reactionsSystemic reactogenicity (e.g., fever)Potential for inflammatory responses due to TLR5 activation
06

Interacting drugs

Salmonella Paratyphi A O-specific polysaccharide-FliC conjugate vaccine

2 more in the full profile.

07

Biomarkers

Anti-H:a IgG antibody titerAnti-H:a IgM antibody titerFliC-specific T-cell response

Beyond the preview

Go deeper on Salmonella Paratyphi A flagellin (H:a antigen) (FliC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Paratyphi A flagellin (H:a antigen) (FliC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call